Transcatheter heart procedure for tricuspid valve leaking
Part of Heart & circulation clinical trials.
This trial is studying a heart procedure that is done through catheters (not open-heart surgery) to treat a leaky tricuspid valve. It may help patients who have valve leakage and are candidates for this specific catheter-based approach, and who can return for follow-up visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be scheduled for a catheter-based treatment for a leaking tricuspid valve (your own valve, or a prior repaired valve/bioprosthetic valve).
- Your valve shape must be suitable for a catheter procedure (the team checks your valve anatomy).
- You must be able and willing to sign consent and understand what the study requires.
- You must agree to attend all follow-up visits and examinations during the study.
- If you can’t reliably return for follow-ups, you likely will not be eligible.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how well a new catheter-based valve system works for people with severe (or worse) tricuspid valve leaking who still have symptoms despite medicines. It aims to improve outcomes by treating the leaking valve without open-heart surgery, if your heart structure and overall health fit the study.
This trial tests whether a new minimally invasive valve replacement device (put through a catheter) can improve health in people with severe right-sided tricuspid valve leaking. It’s for patients who are considered too high-risk for standard open-heart tricuspid surgery.
This trial tests a catheter-based procedure (done through the blood vessels) to repair a severely leaky tricuspid valve. It may help people with symptoms or past hospitalizations from tricuspid valve leakage who are higher-risk for standard surgery.
This trial looks at a catheter-based procedure using the TricValve system for people with severe “tricuspid regurgitation” (a leaky tricuspid valve) who are very symptomatic. It may help reduce the backflow and improve heart function, especially for people who are too unwell for or not helped by standard options.
This study collects information about people who are having a transcatheter tricuspid valve procedure (a heart valve treatment done through catheters rather than open-heart surgery). It may help doctors understand safety and outcomes better over time.
This study tests a new, catheter-based procedure to treat moderate-to-severe leaking of the tricuspid valve (a heart valve on the right side). It’s for people who are high surgical risk and might benefit from replacing the valve without open-heart surgery.
Hear when a new Tricuspid Valve Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.